Description: Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, allergy and vitamins, and minerals and supplements. The company exports its products to approximately 59 countries, including Germany, Australia, the United Kingdom, and Russia. It sells its products under the Lantus, Toujeo, Amaryl, Clexane, Cardace, Targocid, Valparin, Allegra, Avil, Combiflam, DePura by Sanofi, and Collaflex brands through independent distributors. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was founded in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
Home Page: www.sanofiindialtd.com
Officers
| Name | Title |
|---|---|
| Mr. Rajaram Narayanan | MD & Director |
| Mr. Girish Arjan Tekchandani | Compliance Officer & Company Sec. |
| Mr. Cherian Mathew | Head of Manufacturing Operations and Additional Director & Whole Time Director |
| Mr. M. K. Narayanaswamy B.Com.,A.I.C.W.A. | Sr. Director of Accounting & Taxation |
| Ms. J. Yasmin Cama | Sr. Director of Legal Affairs & Legal Affairs - South Asia |
Exchange: BSE
Country: IN : India
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 29.3674 |
| Price-to-Book MRQ: | 9.311 |
| Price-to-Sales TTM: | 4.918 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3426 |